| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 15.603 | 34.720 | 38.014 | 37.161 | 37.514 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | 15.603 | 34.720 | 38.014 | 37.161 | 37.527 | 28 | 1.059 | 846 | 12.684 |
| Total Expenses - EUR | - | 634 | 899 | 2.004 | 884 | 9.829 | 14.428 | 17.733 | 15.956 | 16.406 |
| Gross Profit/Loss - EUR | - | 14.969 | 33.821 | 36.010 | 36.277 | 27.698 | -14.400 | -16.674 | -15.110 | -3.723 |
| Net Profit/Loss - EUR | - | 14.501 | 32.780 | 34.870 | 35.162 | 26.659 | -14.400 | -16.674 | -15.110 | -4.046 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Ortotase Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 1.112 | 967 | 826 | 24.289 | 36.123 | 25.240 | 12.351 | 0 |
| Current Assets | - | 15.181 | 32.149 | 66.500 | 68.935 | 80.961 | 69.710 | 62.015 | 3.937 | 12.171 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 2.173 | 2.774 | 6.922 | 4.760 | 4.389 | 108 | 98 | 98 | 97 |
| Cash | - | 13.009 | 29.375 | 59.578 | 64.175 | 76.573 | 69.602 | 61.917 | 3.839 | 12.073 |
| Shareholders Funds | - | 14.545 | 32.832 | 34.921 | 35.213 | 61.204 | 45.609 | 29.077 | 13.878 | 9.755 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 202 | 203 | 202 | 201 |
| Debts | - | 636 | 428 | 32.545 | 34.548 | 44.268 | 60.546 | 57.552 | 2.597 | 2.416 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 1.087 | 319 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5510 - 5510" | |||||||||
| CAEN Financial Year |
5510
|
|||||||||
Comments - Ortotase Srl